img

Global Cobamamide for Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cobamamide for Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Cobamamide is mainly used for megaloblastic anemia, malnutrition anemia, pregnancy anemia, polyneuritis, radiculopathy, trigeminal neuralgia, sciatica, nerve palsy, it can also be used for nutritional disorders, radiation, and drug-induced leukopenia.
Cobamamide for Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cobamamide for Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cobamamide for Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Cobamamide for Injection key manufacturers include Haerbin Medisan, North China Pharmaceutical Group, Chongqing Yaoyou Pharmaceutical, Hainan Star Pharmaceutical, Hebei Zhitong Biopharmaceutical, Jiangsu Jiuxu Pharmaceutical and Jiuquan Dadeli pharmaceutical, etc. Haerbin Medisan, North China Pharmaceutical Group, Chongqing Yaoyou Pharmaceutical are top 3 players and held % sales share in total in 2022.
Cobamamide for Injection can be divided into 0.5mg, 1.0mg and 1.5mg,, etc. 0.5mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Cobamamide for Injection is widely used in various fields, such as Hospital, Drug Store and Other,, etc. Hospital provides greatest supports to the Cobamamide for Injection industry development. In 2022, global % sales of Cobamamide for Injection went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cobamamide for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Haerbin Medisan
North China Pharmaceutical Group
Chongqing Yaoyou Pharmaceutical
Hainan Star Pharmaceutical
Hebei Zhitong Biopharmaceutical
Jiangsu Jiuxu Pharmaceutical
Jiuquan Dadeli pharmaceutical
Segment by Type
0.5mg
1.0mg
1.5mg

Segment by Application


Hospital
Drug Store
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cobamamide for Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cobamamide for Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cobamamide for Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Cobamamide for Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cobamamide for Injection introduction, etc. Cobamamide for Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Cobamamide for Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Cobamamide for Injection Market Overview
1.1 Cobamamide for Injection Product Overview
1.2 Cobamamide for Injection Market Segment by Type
1.2.1 0.5mg
1.2.2 1.0mg
1.2.3 1.5mg
1.3 Global Cobamamide for Injection Market Size by Type
1.3.1 Global Cobamamide for Injection Market Size Overview by Type (2024-2034)
1.3.2 Global Cobamamide for Injection Historic Market Size Review by Type (2024-2024)
1.3.3 Global Cobamamide for Injection Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cobamamide for Injection Sales Breakdown by Type (2024-2024)
1.4.2 Europe Cobamamide for Injection Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Cobamamide for Injection Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Cobamamide for Injection Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Cobamamide for Injection Sales Breakdown by Type (2024-2024)
2 Global Cobamamide for Injection Market Competition by Company
2.1 Global Top Players by Cobamamide for Injection Sales (2024-2024)
2.2 Global Top Players by Cobamamide for Injection Revenue (2024-2024)
2.3 Global Top Players by Cobamamide for Injection Price (2024-2024)
2.4 Global Top Manufacturers Cobamamide for Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cobamamide for Injection Market Competitive Situation and Trends
2.5.1 Cobamamide for Injection Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Cobamamide for Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cobamamide for Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Cobamamide for Injection Market
2.8 Key Manufacturers Cobamamide for Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cobamamide for Injection Status and Outlook by Region
3.1 Global Cobamamide for Injection Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Cobamamide for Injection Historic Market Size by Region
3.2.1 Global Cobamamide for Injection Sales in Volume by Region (2024-2024)
3.2.2 Global Cobamamide for Injection Sales in Value by Region (2024-2024)
3.2.3 Global Cobamamide for Injection Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Cobamamide for Injection Forecasted Market Size by Region
3.3.1 Global Cobamamide for Injection Sales in Volume by Region (2024-2034)
3.3.2 Global Cobamamide for Injection Sales in Value by Region (2024-2034)
3.3.3 Global Cobamamide for Injection Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Cobamamide for Injection by Application
4.1 Cobamamide for Injection Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.1.3 Other
4.2 Global Cobamamide for Injection Market Size by Application
4.2.1 Global Cobamamide for Injection Market Size Overview by Application (2024-2034)
4.2.2 Global Cobamamide for Injection Historic Market Size Review by Application (2024-2024)
4.2.3 Global Cobamamide for Injection Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cobamamide for Injection Sales Breakdown by Application (2024-2024)
4.3.2 Europe Cobamamide for Injection Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Cobamamide for Injection Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Cobamamide for Injection Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Cobamamide for Injection Sales Breakdown by Application (2024-2024)
5 North America Cobamamide for Injection by Country
5.1 North America Cobamamide for Injection Historic Market Size by Country
5.1.1 North America Cobamamide for Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Cobamamide for Injection Sales in Volume by Country (2024-2024)
5.1.3 North America Cobamamide for Injection Sales in Value by Country (2024-2024)
5.2 North America Cobamamide for Injection Forecasted Market Size by Country
5.2.1 North America Cobamamide for Injection Sales in Volume by Country (2024-2034)
5.2.2 North America Cobamamide for Injection Sales in Value by Country (2024-2034)
6 Europe Cobamamide for Injection by Country
6.1 Europe Cobamamide for Injection Historic Market Size by Country
6.1.1 Europe Cobamamide for Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Cobamamide for Injection Sales in Volume by Country (2024-2024)
6.1.3 Europe Cobamamide for Injection Sales in Value by Country (2024-2024)
6.2 Europe Cobamamide for Injection Forecasted Market Size by Country
6.2.1 Europe Cobamamide for Injection Sales in Volume by Country (2024-2034)
6.2.2 Europe Cobamamide for Injection Sales in Value by Country (2024-2034)
7 Asia-Pacific Cobamamide for Injection by Region
7.1 Asia-Pacific Cobamamide for Injection Historic Market Size by Region
7.1.1 Asia-Pacific Cobamamide for Injection Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Cobamamide for Injection Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Cobamamide for Injection Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Cobamamide for Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Cobamamide for Injection Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Cobamamide for Injection Sales in Value by Region (2024-2034)
8 Latin America Cobamamide for Injection by Country
8.1 Latin America Cobamamide for Injection Historic Market Size by Country
8.1.1 Latin America Cobamamide for Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Cobamamide for Injection Sales in Volume by Country (2024-2024)
8.1.3 Latin America Cobamamide for Injection Sales in Value by Country (2024-2024)
8.2 Latin America Cobamamide for Injection Forecasted Market Size by Country
8.2.1 Latin America Cobamamide for Injection Sales in Volume by Country (2024-2034)
8.2.2 Latin America Cobamamide for Injection Sales in Value by Country (2024-2034)
9 Middle East and Africa Cobamamide for Injection by Country
9.1 Middle East and Africa Cobamamide for Injection Historic Market Size by Country
9.1.1 Middle East and Africa Cobamamide for Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Cobamamide for Injection Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Cobamamide for Injection Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Cobamamide for Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Cobamamide for Injection Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Cobamamide for Injection Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Haerbin Medisan
10.1.1 Haerbin Medisan Company Information
10.1.2 Haerbin Medisan Introduction and Business Overview
10.1.3 Haerbin Medisan Cobamamide for Injection Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Haerbin Medisan Cobamamide for Injection Products Offered
10.1.5 Haerbin Medisan Recent Development
10.2 North China Pharmaceutical Group
10.2.1 North China Pharmaceutical Group Company Information
10.2.2 North China Pharmaceutical Group Introduction and Business Overview
10.2.3 North China Pharmaceutical Group Cobamamide for Injection Sales, Revenue and Gross Margin (2024-2024)
10.2.4 North China Pharmaceutical Group Cobamamide for Injection Products Offered
10.2.5 North China Pharmaceutical Group Recent Development
10.3 Chongqing Yaoyou Pharmaceutical
10.3.1 Chongqing Yaoyou Pharmaceutical Company Information
10.3.2 Chongqing Yaoyou Pharmaceutical Introduction and Business Overview
10.3.3 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Products Offered
10.3.5 Chongqing Yaoyou Pharmaceutical Recent Development
10.4 Hainan Star Pharmaceutical
10.4.1 Hainan Star Pharmaceutical Company Information
10.4.2 Hainan Star Pharmaceutical Introduction and Business Overview
10.4.3 Hainan Star Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Hainan Star Pharmaceutical Cobamamide for Injection Products Offered
10.4.5 Hainan Star Pharmaceutical Recent Development
10.5 Hebei Zhitong Biopharmaceutical
10.5.1 Hebei Zhitong Biopharmaceutical Company Information
10.5.2 Hebei Zhitong Biopharmaceutical Introduction and Business Overview
10.5.3 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Products Offered
10.5.5 Hebei Zhitong Biopharmaceutical Recent Development
10.6 Jiangsu Jiuxu Pharmaceutical
10.6.1 Jiangsu Jiuxu Pharmaceutical Company Information
10.6.2 Jiangsu Jiuxu Pharmaceutical Introduction and Business Overview
10.6.3 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Products Offered
10.6.5 Jiangsu Jiuxu Pharmaceutical Recent Development
10.7 Jiuquan Dadeli pharmaceutical
10.7.1 Jiuquan Dadeli pharmaceutical Company Information
10.7.2 Jiuquan Dadeli pharmaceutical Introduction and Business Overview
10.7.3 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Products Offered
10.7.5 Jiuquan Dadeli pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cobamamide for Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cobamamide for Injection Industrial Chain Analysis
11.4 Cobamamide for Injection Market Dynamics
11.4.1 Cobamamide for Injection Industry Trends
11.4.2 Cobamamide for Injection Market Drivers
11.4.3 Cobamamide for Injection Market Challenges
11.4.4 Cobamamide for Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cobamamide for Injection Distributors
12.3 Cobamamide for Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 0.5mg
Table 2. Major Company of 1.0mg
Table 3. Major Company of 1.5mg
Table 4. Global Cobamamide for Injection Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Cobamamide for Injection Sales by Type (2024-2024) & (Kg)
Table 6. Global Cobamamide for Injection Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Cobamamide for Injection Sales by Type (2024-2024) & (US& Million)
Table 8. Global Cobamamide for Injection Market Share in Value by Type (2024-2024)
Table 9. Global Cobamamide for Injection Price by Type (2024-2024) & (US$/g)
Table 10. Global Cobamamide for Injection Sales by Type (2024-2034) & (Kg)
Table 11. Global Cobamamide for Injection Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Cobamamide for Injection Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Cobamamide for Injection Sales Market Share in Value by Type (2024-2034)
Table 14. Global Cobamamide for Injection Price by Type (2024-2034) & (US$/g)
Table 15. North America Cobamamide for Injection Sales by Type (2024-2024) & (Kg)
Table 16. North America Cobamamide for Injection Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Cobamamide for Injection Sales (Kg) by Type (2024-2024)
Table 18. Europe Cobamamide for Injection Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Cobamamide for Injection Sales (Kg) by Type (2024-2024)
Table 20. Asia-Pacific Cobamamide for Injection Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Cobamamide for Injection Sales (Kg) by Type (2024-2024)
Table 22. Latin America Cobamamide for Injection Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Cobamamide for Injection Sales (Kg) by Type (2024-2024)
Table 24. Middle East and Africa Cobamamide for Injection Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Cobamamide for Injection Sales by Company (2024-2024) & (Kg)
Table 26. Global Cobamamide for Injection Sales Share by Company (2024-2024)
Table 27. Global Cobamamide for Injection Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Cobamamide for Injection Revenue Share by Company (2024-2024)
Table 29. Global Market Cobamamide for Injection Price by Company (2024-2024) & (US$/g)
Table 30. Global Cobamamide for Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Cobamamide for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cobamamide for Injection as of 2022)
Table 33. Date of Key Manufacturers Enter into Cobamamide for Injection Market
Table 34. Key Manufacturers Cobamamide for Injection Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Cobamamide for Injection Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Cobamamide for Injection Sales by Region (2024-2024) & (Kg)
Table 38. Global Cobamamide for Injection Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Cobamamide for Injection Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Cobamamide for Injection Sales Market Share in Value by Region (2024-2024)
Table 41. Global Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2024-2024)
Table 42. Global Cobamamide for Injection Sales by Region (2024-2034) & (Kg)
Table 43. Global Cobamamide for Injection Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Cobamamide for Injection Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Cobamamide for Injection Sales Market Share in Value by Region (2024-2034)
Table 46. Global Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2024-2034)
Table 47. Global Cobamamide for Injection Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Cobamamide for Injection Sales by Application (2024-2024) & (Kg)
Table 49. Global Cobamamide for Injection Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Cobamamide for Injection Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Cobamamide for Injection Sales Market Share in Value by Application (2024-2024)
Table 52. Global Cobamamide for Injection Price by Application (2024-2024) & (US$/g)
Table 53. Global Cobamamide for Injection Sales by Application (2024-2034) & (Kg)
Table 54. Global Cobamamide for Injection Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Cobamamide for Injection Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Cobamamide for Injection Sales Market Share in Value by Application (2024-2034)
Table 57. Global Cobamamide for Injection Price by Application (2024-2034) & (US$/g)
Table 58. North America Cobamamide for Injection Sales by Application (2024-2024) (Kg)
Table 59. North America Cobamamide for Injection Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Cobamamide for Injection Sales by Application (2024-2024) (Kg)
Table 61. Europe Cobamamide for Injection Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Cobamamide for Injection Sales by Application (2024-2024) (Kg)
Table 63. Asia-Pacific Cobamamide for Injection Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Cobamamide for Injection Sales by Application (2024-2024) (Kg)
Table 65. Latin America Cobamamide for Injection Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Cobamamide for Injection Sales by Application (2024-2024) (Kg)
Table 67. Middle East and Africa Cobamamide for Injection Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Cobamamide for Injection Sales by Country (2024-2024) & (Kg)
Table 69. North America Cobamamide for Injection Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Cobamamide for Injection Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Cobamamide for Injection Sales Market Share in Value by Country (2024-2024)
Table 72. North America Cobamamide for Injection Sales by Country (2024-2034) & (Kg)
Table 73. North America Cobamamide for Injection Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Cobamamide for Injection Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Cobamamide for Injection Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Cobamamide for Injection Sales by Country (2024-2024) & (Kg)
Table 77. Europe Cobamamide for Injection Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Cobamamide for Injection Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Cobamamide for Injection Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Cobamamide for Injection Sales by Country (2024-2034) & (Kg)
Table 81. Europe Cobamamide for Injection Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Cobamamide for Injection Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Cobamamide for Injection Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Cobamamide for Injection Sales by Region (2024-2024) & (Kg)
Table 85. Asia-Pacific Cobamamide for Injection Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Cobamamide for Injection Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Cobamamide for Injection Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Cobamamide for Injection Sales by Region (2024-2034) & (Kg)
Table 89. Asia-Pacific Cobamamide for Injection Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Cobamamide for Injection Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Cobamamide for Injection Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Cobamamide for Injection Sales by Country (2024-2024) & (Kg)
Table 93. Latin America Cobamamide for Injection Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Cobamamide for Injection Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Cobamamide for Injection Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Cobamamide for Injection Sales by Country (2024-2034) & (Kg)
Table 97. Latin America Cobamamide for Injection Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Cobamamide for Injection Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Cobamamide for Injection Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Cobamamide for Injection Sales by Country (2024-2024) & (Kg)
Table 101. Middle East and Africa Cobamamide for Injection Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Cobamamide for Injection Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Cobamamide for Injection Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Cobamamide for Injection Sales by Country (2024-2034) & (Kg)
Table 105. Middle East and Africa Cobamamide for Injection Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Cobamamide for Injection Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Cobamamide for Injection Sales Market Share in Value by Country (2024-2034)
Table 108. Haerbin Medisan Company Information
Table 109. Haerbin Medisan Introduction and Business Overview
Table 110. Haerbin Medisan Cobamamide for Injection Sales (Kg), Revenue (Million USD), Price (US$/g) and Gross Margin (2024-2024)
Table 111. Haerbin Medisan Cobamamide for Injection Product
Table 112. Haerbin Medisan Recent Development
Table 113. North China Pharmaceutical Group Company Information
Table 114. North China Pharmaceutical Group Introduction and Business Overview
Table 115. North China Pharmaceutical Group Cobamamide for Injection Sales (Kg), Revenue (Million USD), Price (US$/g) and Gross Margin (2024-2024)
Table 116. North China Pharmaceutical Group Cobamamide for Injection Product
Table 117. North China Pharmaceutical Group Recent Development
Table 118. Chongqing Yaoyou Pharmaceutical Company Information
Table 119. Chongqing Yaoyou Pharmaceutical Introduction and Business Overview
Table 120. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (Million USD), Price (US$/g) and Gross Margin (2024-2024)
Table 121. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product
Table 122. Chongqing Yaoyou Pharmaceutical Recent Development
Table 123. Hainan Star Pharmaceutical Company Information
Table 124. Hainan Star Pharmaceutical Introduction and Business Overview
Table 125. Hainan Star Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (Million USD), Price (US$/g) and Gross Margin (2024-2024)
Table 126. Hainan Star Pharmaceutical Cobamamide for Injection Product
Table 127. Hainan Star Pharmaceutical Recent Development
Table 128. Hebei Zhitong Biopharmaceutical Company Information
Table 129. Hebei Zhitong Biopharmaceutical Introduction and Business Overview
Table 130. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales (Kg), Revenue (Million USD), Price (US$/g) and Gross Margin (2024-2024)
Table 131. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product
Table 132. Hebei Zhitong Biopharmaceutical Recent Development
Table 133. Jiangsu Jiuxu Pharmaceutical Company Information
Table 134. Jiangsu Jiuxu Pharmaceutical Introduction and Business Overview
Table 135. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (Million USD), Price (US$/g) and Gross Margin (2024-2024)
Table 136. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product
Table 137. Jiangsu Jiuxu Pharmaceutical Recent Development
Table 138. Jiuquan Dadeli pharmaceutical Company Information
Table 139. Jiuquan Dadeli pharmaceutical Introduction and Business Overview
Table 140. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (Million USD), Price (US$/g) and Gross Margin (2024-2024)
Table 141. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product
Table 142. Jiuquan Dadeli pharmaceutical Recent Development
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Cobamamide for Injection Market Trends
Table 146. Cobamamide for Injection Market Drivers
Table 147. Cobamamide for Injection Market Challenges
Table 148. Cobamamide for Injection Market Restraints
Table 149. Cobamamide for Injection Distributors List
Table 150. Cobamamide for Injection Downstream Customers
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Cobamamide for Injection Product Picture
Figure 2. Global Cobamamide for Injection Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Cobamamide for Injection Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Cobamamide for Injection Sales Status and Outlook (2024-2034) & (Kg)
Figure 5. Product Picture of 0.5mg
Figure 6. Global 0.5mg Sales YoY Growth (2024-2034) & (Kg)
Figure 7. Product Picture of 1.0mg
Figure 8. Global 1.0mg Sales YoY Growth (2024-2034) & (Kg)
Figure 9. Product Picture of 1.5mg
Figure 10. Global 1.5mg Sales YoY Growth (2024-2034) & (Kg)
Figure 11. Global Cobamamide for Injection Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Cobamamide for Injection Sales Market Share by Type in 2022 & 2034
Figure 13. North America Cobamamide for Injection Sales Market Share in Volume by Type in 2022
Figure 14. North America Cobamamide for Injection Sales Market Share in Value by Type in 2022
Figure 15. Europe Cobamamide for Injection Sales Market Share in Volume by Type in 2022
Figure 16. Europe Cobamamide for Injection Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Cobamamide for Injection Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Cobamamide for Injection Sales Market Share in Value by Type in 2022
Figure 19. Latin America Cobamamide for Injection Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Cobamamide for Injection Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Cobamamide for Injection Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Cobamamide for Injection Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Cobamamide for Injection Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Cobamamide for Injection Revenue in 2022
Figure 25. Cobamamide for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2024-2034) & (Kg)
Figure 28. Product Picture of Drug Store
Figure 29. Global Drug Store Sales YoY Growth (2024-2034) & (Kg)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2024-2034) & (Kg)
Figure 32. Global Cobamamide for Injection Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Cobamamide for Injection Sales Market Share by Application in 2022 & 2034
Figure 34. North America Cobamamide for Injection Sales Market Share in Volume by Application in 2022
Figure 35. North America Cobamamide for Injection Sales Market Share in Value by Application in 2022
Figure 36. Europe Cobamamide for Injection Sales Market Share in Volume by Application in 2022
Figure 37. Europe Cobamamide for Injection Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Cobamamide for Injection Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Cobamamide for Injection Sales Market Share in Value by Application in 2022
Figure 40. Latin America Cobamamide for Injection Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Cobamamide for Injection Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Cobamamide for Injection Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Cobamamide for Injection Manufacturing Cost Structure
Figure 45. Cobamamide for Injection Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed